Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 350432, 8 pages
http://dx.doi.org/10.1155/2014/350432
Review Article

Novel Approach to Reactive Oxygen Species in Nontransfusion-Dependent Thalassemia

1Department of Physiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
2Department of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Beirut, Lebanon

Received 28 February 2014; Accepted 7 June 2014; Published 9 July 2014

Academic Editor: Aurelio Maggio

Copyright © 2014 Paul I. Tyan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Fucharoen, P. Ketvichit, P. Pootrakul, N. Siritanaratkul, A. Piankijagum, and P. Wasi, “Clinical manifestation of β-thalassemia/hemoglobin E disease,” Journal of Pediatric Hematology/Oncology, vol. 22, no. 6, pp. 552–557, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Aessopos, D. Farmakis, S. Deftereos et al., “Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia,” Chest, vol. 127, no. 5, pp. 1523–1530, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Fucharoen and P. Winichagoon, “New updating into hemoglobinopathies,” International Journal of Laboratory Hematology, vol. 34, no. 6, pp. 559–565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Sripichai, W. Makarasara, T. Munkongdee et al., “A scoring system for the classification of β-thalassemia/Hb E disease severity,” American Journal of Hematology, vol. 83, no. 6, pp. 482–484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Fucharoen and P. Winichagoon, “Hemoglobinopathies in Southeast Asia,” Hemoglobin, vol. 11, no. 1, pp. 65–88, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. S. C. Tso, T. T. Loh, and D. Todd, “Iron overload in patients with haemoglobin H disease,” Scandinavian Journal of Haematology, vol. 32, no. 4, pp. 391–394, 1984. View at Google Scholar · View at Scopus
  7. B. Modell and M. Darlison, “Global epidemiology of haemoglobin disorders and derived service indicators,” Bulletin of the World Health Organization, vol. 86, no. 6, pp. 480–487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Musallam, S. Rivella, E. Vichinsky, and E. A. Rachmilewitz, “Non-transfusion-dependent thalassemias,” Haematologica, vol. 98, no. 6, pp. 833–844, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Weatherall, “The definition and epidemiology of non-transfusion-dependent thalassemia,” Blood Reviews, vol. 26, no. 1, pp. S3–S6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Restivo Pantalone, D. Renda, F. Valenza et al., “Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience,” The British Journal of Haematology, vol. 150, no. 2, pp. 245–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Borgna-Pignatti, G. Vergine, T. Lombardo et al., “Hepatocellular carcinoma in the thalassaemia syndromes,” British Journal of Haematology, vol. 124, no. 1, pp. 114–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Mancuso, “Hepatocellular carcinoma in thalassemia: a critical review,” World Journal of Hepatology, vol. 2, no. 5, pp. 171–174, 2010. View at Google Scholar
  13. A. Taher, C. Hershko, and M. D. Cappellini, “Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies,” British Journal of Haematology, vol. 147, no. 5, pp. 634–640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Taher, K. M. Musallam, F. El Rassi et al., “Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia,” British Journal of Haematology, vol. 146, no. 5, pp. 569–572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. T. Taher, K. M. Musallam, A. El-Beshlawy et al., “Age-related complications in treatment-naïve patients with thalassaemia intermedia,” British Journal of Haematology, vol. 150, no. 4, pp. 486–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Origa, S. Barella, G. M. Argiolas, P. Bina, A. Agus, and R. Galanello, “No evidence of cardiac iron in 20 neveror minimally-transfused patients with thalassemia intermedia,” Haematologica, vol. 93, no. 7, pp. 1095–1096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. T. Taher, K. M. Musallam, J. C. Wood, and M. D. Cappellini, “Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients,” American Journal of Hematology, vol. 85, no. 4, pp. 288–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Roghi, M. D. Cappellini, J. C. Wood et al., “Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study,” Annals of Hematology, vol. 89, no. 6, pp. 585–589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Mavrogeni, E. Gotsis, V. Ladis et al., “Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major,” International Journal of Cardiovascular Imaging, vol. 24, no. 8, pp. 849–854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Nemeth, M. S. Tuttle, J. Powelson et al., “Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization,” Science, vol. 306, no. 5704, pp. 2090–2093, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Haidar, H. Mhaidli, and A. T. Taher, “Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia,” European Spine Journal, vol. 19, no. 6, pp. 871–878, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. G. L. Semenza, “Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis,” Blood, vol. 114, no. 10, pp. 2015–2019, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. F. E. Chen, C. Ooi, S. Y. Ha et al., “Genetic and clinical features of hemoglobin H disease in Chinese patients,” The New England Journal of Medicine, vol. 343, no. 8, pp. 544–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Hershko, “Pathogenesis and management of iron toxicity in thalassemia,” Annals of the New York Academy of Sciences, vol. 1202, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Fibach and E. A. Rachmilewitz, “The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia,” Annals of the New York Academy of Sciences, vol. 1202, pp. 10–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Halliwell and J. M. C. Gutteridge, “Biologically relevant metal ion-dependent hydroxyl radical generation. An update,” FEBS Letters, vol. 307, no. 1, pp. 108–112, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Cadenas, “Biochemistry of oxygen toxicity,” Annual Review of Biochemistry, vol. 58, pp. 79–110, 1989. View at Publisher · View at Google Scholar · View at Scopus
  28. K. M. Musallam, I. Motta, M. Salvatori et al., “Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia,” Blood Cells, Molecules, and Diseases, vol. 49, no. 3-4, pp. 136–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. E. Maakaron, M. D. Cappellini, G. Graziadei, J. B. Ayache, and A. T. Taher, “Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis,” Annals of Hepatology, vol. 12, no. 1, pp. 142–146, 2013. View at Google Scholar · View at Scopus
  30. G. Restivo Pantalone, D. Renda, F. Valenza et al., “Hepatocellular carcinoma in patients with thalassaemia syndromes: Clinical characteristics and outcome in a long term single centre experience,” British Journal of Haematology, vol. 150, no. 2, pp. 245–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. E. Maakaron, K. M. Musallam, J. B. Ayache, M. Jabbour, A. N. Tawil, and A. T. Taher, “A liver mass in an iron-overloaded thalassaemia intermedia patient,” British Journal of Haematology, vol. 161, no. 1, p. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Napoli, E. Carmina, S. Bucchieri, C. Sferrazza, G. B. Rini, and G. di Fede, “Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia,” Bone, vol. 38, no. 6, pp. 888–892, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Haidar, K. M. Musallam, and A. T. Taher, “Bone disease and skeletal complications in patients with β thalassemia major,” Bone, vol. 48, no. 3, pp. 425–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. K. M. Musallam, M. D. Cappellini, J. C. Wood et al., “Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia,” Haematologica, vol. 96, no. 11, pp. 1605–1612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. H. Nassar, M. Naja, C. Cesaretti, B. Eprassi, M. D. Cappellini, and A. Taher, “Pregnancy outcome in patients with β-thalassemia intermedia at two tertiary care centers, in Beirut and Milan,” Haematologica, vol. 93, no. 10, pp. 1586–1587, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. H. Nassar, I. M. Usta, and A. M. Taher, “β-Thalassemia intermedia and pregnancy: should we anticoagulate?” Journal of Thrombosis and Haemostasis, vol. 4, no. 6, pp. 1413–1414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Eldor and E. A. Rachmilewitz, “The hypercoagulable state in thalassemia,” Blood, vol. 99, no. 1, pp. 36–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Eldor, R. Durst, E. Hy-Am et al., “A chronic hypercoagulable state in patients with β-thalassaemia major is already present in childhood,” British Journal of Haematology, vol. 107, no. 4, pp. 739–746, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. M. D. Cappellini, K. M. Musallam, E. Poggiali, and A. T. Taher, “Hypercoagulability in non-transfusion-dependent thalassemia,” Blood Reviews, vol. 26, supplement 1, pp. S20–S23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. D. Cappellini, E. Poggiali, A. T. Taher, and K. M. Musallam, “Hypercoagulability in β-thalassemia: a status quo,” Expert Review of Hematology, vol. 5, no. 5, pp. 505–512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. D. Cappellini, I. Motta, K. M. Musallam, and A. T. Taher, “Redefining thalassemia as a hypercoagulable state,” Annals of the New York Academy of Sciences, vol. 1202, pp. 231–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. K. I. Ataga, M. D. Cappellini, and E. A. Rachmilewitz, “β-Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability,” British Journal of Haematology, vol. 139, no. 1, pp. 3–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. K. M. Musallam and A. T. Taher, “Thrombosis in thalassemia: why are we so concerned?” Hemoglobin, vol. 35, no. 5-6, pp. 503–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. K. M. Musallam, A. T. Taher, and E. A. Rachmilewitz, “β-thalassemia intermedia: a clinical perspective.,” Cold Spring Harbor perspectives in medicine, vol. 2, no. 7, p. a013482, 2012. View at Google Scholar · View at Scopus
  45. K. Parsa and A. Oreizy, “Nonsurgical approach to paraparesis due to extramedullary hematopoiesis. Report of two cases,” Journal of Neurosurgery, vol. 82, no. 4, pp. 657–660, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. B. M. Brenner, E. V. Lawler, and H. S. Mackenzie, “The hyperfiltration theory: a paradigm shift in nephrology,” Kidney International, vol. 49, no. 6, pp. 1774–1777, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Ponticelli, K. M. Musallam, P. Cianciulli, and M. D. Cappellini, “Renal complications in transfusion-dependent beta thalassaemia,” Blood Reviews, vol. 24, no. 6, pp. 239–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Sumboonnanonda, P. Malasit, V. S. Tanphaichitr, S. Ong-ajyooth, S. Petrarat, and A. Vongjirad, “Renal tubular dysfunction in α-thalassemia,” Pediatric Nephrology, vol. 18, no. 3, pp. 257–260, 2003. View at Google Scholar · View at Scopus
  49. N. S. Mallat, S. G. Mallat, K. M. Musallam, and A. T. Taher, “Potential mechanisms for renal damage in beta-thalassemia,” Journal of Nephrology, vol. 26, no. 5, pp. 821–148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Dore, S. Pardini, E. Gaviano et al., “Recurrence of spinal cord compression from extramedullary hematopoiesis in thalassemia intermedia treated with low doses of radiotherapy,” American Journal of Hematology, vol. 44, no. 2, p. 148, 1993. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Amer, A. Goldfarb, E. A. Rachmilewitz, and E. Fibach, “Fermented papaya preparation as redox regulator in blood cells of β-thalassemic mice and patients,” Phytotherapy Research, vol. 22, no. 6, pp. 820–828, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Fibach, E. Tan, S. Jamuar, I. Ng, J. Amer, and E. A. Rachmilewitz, “Amelioration of oxidative stress in red blood cells from patients with β-thalassemia major and intermedia and E-β-thalassemia following administration of a fermented papaya preparation,” Phytotherapy Research, vol. 24, no. 9, pp. 1334–1338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. R. W. Kalpravidh, N. Siritanaratkul, P. Insain et al., “Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids,” Clinical Biochemistry, vol. 43, no. 4-5, pp. 424–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. L. N. Grinberg, O. Shalev, H. H. Tønnesen, and E. A. Rachmilewitz, “Studies on curcumin and curcuminoids: XXVI. Antioxidant effects of curcumin on the red blood cell membrane,” International Journal of Pharmaceutics, vol. 132, no. 1-2, pp. 251–257, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Srichairatanakool, C. Thephinlap, C. Phisalaphong, J. B. Porter, and S. Fucharoen, “Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma,” Medicinal Chemistry, vol. 3, no. 5, pp. 469–474, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Modell, M. Khan, and M. Darlison, “Survival in β-thalassaemia major in the UK: Data from the UK thalassaesnia register,” The Lancet, vol. 355, no. 9220, pp. 2051–2052, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Miniero, E. Canducci, D. Ghigo, P. Saracco, and C. Vullo, “Vitamin E in beta-thalassemia,” Acta Vitaminologica et Enzymologica, vol. 4, no. 1-2, pp. 21–25, 1982. View at Google Scholar · View at Scopus
  58. L. Tesoriere, D. D'Arpa, D. Butera et al., “Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β-thalassemia intermedia patients,” Free Radical Research, vol. 34, no. 5, pp. 529–540, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. I. Kahane and E. A. Rachmilewitz, “Alterations in the red blood cell membrane and the effect of vitamin E on osmotic fragility in β thalassemia major,” Israel Journal of Medical Sciences, vol. 12, no. 1, pp. 11–15, 1976. View at Google Scholar · View at Scopus
  60. O. Giardini, A. Cantani, A. Donfrancesco et al., “Biochemical and clinical effects of vitamin E administration in homozygous beta-thalassemia,” Acta Vitaminologica et Enzymologica, vol. 7, no. 1-2, pp. 55–60, 1985. View at Google Scholar · View at Scopus
  61. T. L. Clanton, “Hypoxia-induced reactive oxygen species formation in skeletal muscle,” Journal of Applied Physiology, vol. 102, no. 6, pp. 2379–2388, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” The Journal of Physiology, vol. 552, part 2, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Koechlin, F. Maltais, D. Saey et al., “Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease,” Thorax, vol. 60, no. 10, pp. 834–841, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Cannon, I. G. Shabalina, T. V. Kramarova, N. Petrovic, and J. Nedergaard, “Uncoupling proteins: a role in protection against reactive oxygen species—or not?” Biochimica et Biophysica Acta: Bioenergetics, vol. 1757, no. 5-6, pp. 449–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Trifunovic and N.-G. Larsson, “Mitochondrial dysfunction as a cause of ageing,” Journal of Internal Medicine, vol. 263, no. 2, pp. 167–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Meral, P. Tuncel, E. Sürmen-Gür, R. Ozbek, E. Oztürk, and U. Günay, “Lipid peroxidation and antioxidant status in beta-thalassemia,” Pediatric Hematology-Oncology, vol. 17, no. 8, pp. 687–693, 2000. View at Publisher · View at Google Scholar
  67. G. Cighetti, L. Duca, L. Bortone et al., “Oxidative status and malondialdehyde in β-thalassaemia patients,” European Journal of Clinical Investigation, vol. 32, supplement 1, pp. 55–60, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Naithani, J. Chandra, J. Bhattacharjee, P. Verma, and S. Narayan, “Peroxidative stress and antioxidant enzymes in children with β-thalassemia major,” Pediatric Blood and Cancer, vol. 46, no. 7, pp. 780–785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Bedard and K. Krause, “The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. H. Wei, S. B. Wu, Y. S. Ma, and H. C. Lee, “Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging,” Chang Gung Medical Journal, vol. 32, no. 2, pp. 113–132, 2009. View at Google Scholar · View at Scopus
  71. A. Di Pietro, B. Baluce, G. Visalli, S. La Maestra, R. Micale, and A. Izzotti, “Ex vivo study for the assessment of behavioral factor and gene polymorphisms in individual susceptibility to oxidative DNA damage metals-induced,” International Journal of Hygiene and Environmental Health, vol. 214, no. 3, pp. 210–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Ferro, G. Visalli, R. Civa et al., “Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects,” Free Radical Biology and Medicine, vol. 53, no. 10, pp. 1829–1837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. E. Pedruzzi, C. Guichard, V. Ollivier et al., “NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells,” Molecular and Cellular Biology, vol. 24, no. 24, pp. 10703–10717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Hwang, M. H. Ing, A. Salazar et al., “Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation,” Circulation Research, vol. 93, no. 12, pp. 1225–1232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. H. B. Suliman, M. Ali, and C. A. Piantadosi, “Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia,” Blood, vol. 104, no. 1, pp. 43–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Vallet, Y. Charnay, K. Steger et al., “Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia,” Neuroscience, vol. 132, no. 2, pp. 233–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Mittal, M. Roth, and P. König, “Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature,” Circulation Research, vol. 101, no. 3, pp. 258–267, 2007. View at Publisher · View at Google Scholar
  78. V. G. DeMarco, J. Habibi, A. T. Whaley-Connell et al., “Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 6, pp. H2659–H2668, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Meyrick and L. Reid, “Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression,” The American Journal of Pathology, vol. 100, no. 1, pp. 151–178, 1980. View at Google Scholar · View at Scopus
  80. B. O. Meyrick and L. M. Reid, “Crotolaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls,” American Journal of Pathology, vol. 106, no. 1, pp. 84–94, 1982. View at Google Scholar · View at Scopus
  81. V. G. DeMarco, A. T. Whaley-Connell, J. R. Sowers Habibi, and K. C. Dellsperger, “Contribution of oxidative stress to pulmonary arterial hypertension,” World Journal of Cardiology, vol. 2, no. 10, pp. 316–324, 2010. View at Publisher · View at Google Scholar
  82. C. S. Boyer, G. L. Bannenberg, E. P. A. Neve, Å. Ryrfeldt, and P. Moldéus, “Evidence for the activation of the signal-responsive phospholipase A2 by exogenous hydrogen peroxide,” Biochemical Pharmacology, vol. 50, no. 6, pp. 753–761, 1995. View at Publisher · View at Google Scholar · View at Scopus
  83. G. N. Rao, M. S. Runge, and R. W. Alexander, “Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells,” Biochimica et Biophysica Acta, vol. 1265, no. 1, pp. 67–72, 1995. View at Google Scholar · View at Scopus
  84. C. D. Fike, S. L. Pfister, M. R. Kaplowitzand, and J. A. Madden, “Cyclooxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs,” Journal of Applied Physiology, vol. 92, no. 1, pp. 67–74, 2002. View at Google Scholar · View at Scopus
  85. A. Bishop, “Role of oxygen in wound healing.,” Journal of wound care, vol. 17, no. 9, pp. 399–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. P. G. Rodriguez, F. N. Felix, D. T. Woodley, and E. K. Shim, “The role of oxygen in wound healing: a review of the literature,” Dermatologic Surgery, vol. 34, no. 9, pp. 1159–1169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. T. J. James, M. A. Hughes, D. Hofman, G. W. Cherry, and R. P. Taylor, “Antioxidant characteristics of chronic wound fluid,” British Journal of Dermatology, vol. 145, no. 1, pp. 185–186, 2001. View at Google Scholar · View at Scopus
  88. R. Moseley, J. E. Stewart, P. Stephens, R. J. Waddington, and D. W. Thomas, “Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases?” British Journal of Dermatology, vol. 150, no. 3, pp. 401–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Carnevale, P. Pignatelli, L. Lenti et al., “LDL are oxidatively modified by platelets via GP91phox and accumulate in human monocytes,” The FASEB Journal, vol. 21, no. 3, pp. 927–934, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. F. Violi, P. Pignatelli, and S. Basili, “Nutrition, supplements, and vitamins in platelet function and bleeding,” Circulation, vol. 121, no. 8, pp. 1033–1044, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Pignatelli, R. Carnevale, S. Di Santo et al., “Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 2, pp. 423–434, 2011. View at Google Scholar
  92. A. J. Begonja, S. Gambaryan, J. R. Geiger et al., “Platelet NAD(P)H-oxidase-generated ROS production regulates αIIbβ3-integrin activation independent of the NO/cGMP pathway,” Blood, vol. 106, no. 8, pp. 2757–2760, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. P. Clutton, A. Miermont, and J. E. Freedman, “Regulation of endogenous reactive oxygen species in platelets can reverse aggregation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 1, pp. 187–192, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. L. Iuliano, J. Z. Pedersen, D. Pratico, G. Rotilio, and F. Violi, “Role of hydroxyl radicals in the activation of human platelets,” European Journal of Biochemistry, vol. 221, no. 2, pp. 695–704, 1994. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Krötz, H. Y. Sohn, T. Gloe et al., “NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment,” Blood, vol. 100, no. 3, pp. 917–924, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. D. Salvemini, W. Radziszewski, V. Mollace, A. Moore, D. Willoughby, and J. Vane, “Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation,” European Journal of Pharmacology, vol. 199, no. 1, pp. 15–18, 1991. View at Publisher · View at Google Scholar · View at Scopus
  97. N. K. Lee, Y. G. Choi, J. Y. Baik et al., “A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation,” Blood, vol. 106, no. 3, pp. 852–859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Yang, P. Madyastha, S. Bingel, W. Ries, and L. Key, “A new superoxide-generating oxidase in murine osteoclasts,” Journal of Biological Chemistry, vol. 276, no. 8, pp. 5452–5458, 2001. View at Publisher · View at Google Scholar · View at Scopus
  99. I. Kusaka, G. Kusaka, C. Zhou et al., “Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 286, no. 6, pp. H2442–H2451, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. C. E. Walder, S. P. Green, W. C. Darbonne et al., “Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase,” Stroke, vol. 28, no. 11, pp. 2252–2258, 1997. View at Publisher · View at Google Scholar · View at Scopus